Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Aclipse Therapeutics LLC See All Filings	D	2020-08-24 12:51:34 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001730907 Filed Document 0001730907-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-08-24 12:51:34 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Aclipse Therapeutics LLC See All Filings	D	2020-03-23 17:05:24 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001730907 Filed Document 0001730907-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-03-23 17:05:24 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Other
Aclipse Therapeutics LLC See All Filings	D	2019-06-19 13:16:44 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001730907 Filed Document 0001730907-19-000005 Exclusions or Exemptions 506b Accepted Date 2019-06-19 13:16:44 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Other
Aclipse Therapeutics LLC See All Filings	D	2019-03-22 16:44:07 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001730907 Filed Document 0001730907-19-000004 Exclusions or Exemptions 506b Accepted Date 2019-03-22 16:44:07 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Other
Aclipse Therapeutics LLC See All Filings	D/A	2019-03-22 16:42:05 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001730907 Filed Document 0001730907-19-000003 Exclusions or Exemptions 506b Accepted Date 2019-03-22 16:42:05 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Aclipse Therapeutics LLC See All Filings	D/A	2019-02-15 10:41:50 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001730907 Filed Document 0001730907-19-000002 Exclusions or Exemptions 506b Accepted Date 2019-02-15 10:41:50 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Aclipse Therapeutics LLC See All Filings	D/A	2018-10-26 11:41:41 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001730907 Filed Document 0001730907-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-10-26 11:41:41 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Aclipse Therapeutics LLC See All Filings	D	2018-02-15 15:36:47 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001730907 Filed Document 0001437377-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-02-15 15:36:47 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity